Literature DB >> 3922078

Similar mechanism of various lupus anticoagulants.

T Exner.   

Abstract

Potent lupus inhibitors from various patients were mixed with platelet free normal plasma and were compared in activated partial thromboplastin time (APTT), dilute prothrombin time (dil. PT), kaolin clotting time (KCT), contact product clotting time (CPCT), and Russell viper venom clotting time (RVVCT) tests. In the last three tests platelets and platelet lipid substitutes were avoided to enhance the sensitivities of these tests for the lupus anticoagulant. Correlations between the KCT and the other tests were mostly good, indicating that different lupus inhibitors functioned by a similar mechanism. There was no significant trend between particular clinical symptoms and individual coagulation test combinations. The KCT was found to be the most sensitive test for the lupus inhibitor, followed by the CPCT, RVVCT, dil. PT and APTT tests. Activated platelets tended to correct the APTT lupus inhibitor defect in all except the strongest inhibitor cases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922078

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Species specificity of lupus-like anticoagulants.

Authors:  L P Clyne
Journal:  Blut       Date:  1986-10

2.  Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome.

Authors:  R A Asherson; H M Fei; H L Staub; M A Khamashta; G R Hughes; R I Fox
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

3.  V gene analysis of anti-cardiolipin antibodies from (NZW x BXSB) F1 mice.

Authors:  Y Kita; T Sumida; I Iwamoto; S Yoshida; T Koike
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

4.  Antiphospholipid syndrome: five year follow up.

Authors:  R A Asherson; E Baguley; C Pal; G R Hughes
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

5.  Detection of anti-bovine beta 2-glycoprotein I antibody in sera from patients with antiphospholipid syndrome.

Authors:  M Nomura; J Okada; H Kondo
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 6.  Antiphospholipid antibodies in paediatrics.

Authors:  A Ravelli; A Martini; G R Burgio
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.